Intensity modulated radiation therapy (IMRT) is a true revolution in the field of radiation oncology. IMRT provides the unprecedented means of conforming does to the shape of the target tissues in 3-dimensions reducing the risk of complications thereby improving the quality of life of irradiated patients. Moreover, IMRT provides the means to deliver higher than conventional doses thus improving the chance of cure in these patients.
More than 100 cases teach how you how to applypharmacotherapeutic concepts to real-world clinical situations
Pharmacotherapy Principles and Practice Study Guide, Third Edition, includes more than 100 patient cases that correspond to chapters in the third edition ofPharmacotherapy Principles and Practice. These cases are presented in realistic fashion, using terms andabbreviations that would normally be found in a patient's medical record. Patients in these cases have drug therapy problems requiring identification and management. Foreach case, you will be asked to develop a Patient Database, Drug Therapy Problem Worksheet, and Pharmacotherapy Care Plan, using the forms provided.With Pharmacotherapy Principles and Practice Study Guide you will learn how to navigate through the process of applying your knowledge of pharmacotherapy to specific patient cases by organizing patient data to logically assess a patient's medication issues and formulate a sound pharmacotherapy care plan.
EACH CASE INCLUDES:
This long overdue title provides a comprehensive, up-to-date, state-of-the art review of approved biologic therapies, with coverage of mechanisms of action, Indications for therapy, immunogenicity and a detailed examination of adverse effects and safety of the many and diverse therapeutic agents presented in a total of 13 chapters. It is predicted that by 2016, biologics will make up half of the world's 20 top-selling drugs and by 2018, biologic medicine sales will account for almost half of the world's 100 biggest selling drugs. Recombinant proteins dominate the growing list of the more than 200 approved biotherapeutic agents with targeted antibodies, fusion proteins and receptors; cytokines; hormones; enzymes; proteins involved in blood-clotting, homeostasis and thrombosis; vaccines; botulinum neurotoxins; and, more recently, biosimilar preparations, comprising the majority of approved biologics. Written with clinicians, other health care professionals, and researchers in mind, Safety of Biologics Therapy examines, in a single volume, the full range of issues surrounding the safety of approved biologic therapies. A good understanding of the risks and safety issues of modern biologics therapy is increasingly being demanded of all those connected with their development, handling, prescribing, administration and subsequent patient management. In addition to being of great value to clinicians in all branches of medicine, and to nurses, pharmacists and researchers, this book will prove invaluable for students taking undergraduate and graduate courses in the above disciplines and in the biomedical sciences.
Energy Products Articles
Energy Products Books